The company's innovative platform technology uses a 3D tissue system to provide physiologically relevant data that is compatible with in vitro bioanalyses. Glauconix collaborates with academic and industry partners to identify and validate the most effective drug candidates, reducing the risk of clinical trial failure and saving time, labor, and development costs. Early identification and validation of effective compounds or biologics allows partners to confidently enter clinical trials. Glauconix operates out of its laboratories located at the SUNY Polytechnic Institute-Albany, NY campus.